- Enrolling by invitationPHASE2
Long-term Safety and Tolerability of BHV-7000
This study looks at the long-term safety of a new medicine, BHV-7000, for adults with focal epilepsy. It's for people who have already taken part in an earlier study for this particular drug. The main goal is to see if the medicine is safe and well-tolerated over a longer time.
For: Focal EpilepsyUnited States · Argentina · Australia - Active not recruitingPHASE2, PHASE3
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
This study is testing a new medicine called BHV-7000 to see if it can help adults with focal epilepsy that hasn't responded well to other treatments. Researchers want to find out if it's safe and effective in reducing seizures.
For: Focal EpilepsyUnited States · Australia · Denmark